Li D, Bao L, Liu S, Ji K, Xu X, Yuan J
Appl Biochem Biotechnol. 2024; .
PMID: 39666232
DOI: 10.1007/s12010-024-05130-y.
Ahmed K, Sheikh A, Fatima S, Ghulam T, Haider G, Abbas F
Sci Rep. 2024; 14(1):10315.
PMID: 38705879
PMC: 11070424.
DOI: 10.1038/s41598-024-60538-0.
Xia W, Shi N, Li C, Tang A
Virulence. 2024; 15(1):2306795.
PMID: 38251668
PMC: 10826628.
DOI: 10.1080/21505594.2024.2306795.
Zhou Z, Zheng K, Zhou S, Yang Y, Chen J, Jin X
J Mol Med (Berl). 2023; 101(12):1543-1565.
PMID: 37796337
DOI: 10.1007/s00109-023-02376-7.
Li G, Yang S, Wang S, Jiang R, Xu X
Diagnostics (Basel). 2023; 13(15).
PMID: 37568893
PMC: 10417831.
DOI: 10.3390/diagnostics13152530.
The Long Noncoding RNA Cytoskeleton Regulator RNA (CYTOR)/miRNA-24-3p Axis Facilitates Nasopharyngeal Carcinoma Progression by Modulating GAD1 Expression.
Du J, Yu W, Peng L, Zhang T
J Oncol. 2023; 2023:6027860.
PMID: 36814556
PMC: 9940962.
DOI: 10.1155/2023/6027860.
Prognostic Epstein-Barr Virus (EBV) miRNA biomarkers for survival outcome in EBV-associated epithelial malignancies: Systematic review and meta-analysis.
Abusalah M, Irekeola A, Shueb R, Jarrar M, Yean Yean C
PLoS One. 2022; 17(4):e0266893.
PMID: 35436288
PMC: 9015129.
DOI: 10.1371/journal.pone.0266893.
Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1/c-Myc positive feedback loop.
Wang Y, Yan Q, Mo Y, Liu Y, Wang Y, Zhang S
Mol Cancer. 2022; 21(1):62.
PMID: 35227262
PMC: 8883650.
DOI: 10.1186/s12943-022-01502-2.
Novel long non-coding RNA lncAMPC downregulates PTEN via miR-214 to promote nasopharyngeal carcinoma progression.
Li X, Ouyang S
Mol Cell Biochem. 2022; 477(3):805-814.
PMID: 35059924
DOI: 10.1007/s11010-021-04323-x.
Non-Coding RNAs: Emerging Therapeutic Targets in Spinal Cord Ischemia-Reperfusion Injury.
Ling X, Lu J, Yang J, Qin H, Zhao X, Zhou P
Front Neurol. 2021; 12:680210.
PMID: 34566835
PMC: 8456115.
DOI: 10.3389/fneur.2021.680210.
Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma.
Siak P, Khoo A, Leong C, Hoh B, Cheah S
Cancers (Basel). 2021; 13(14).
PMID: 34298701
PMC: 8305767.
DOI: 10.3390/cancers13143490.
FBXL19‑AS1 promotes the progression of nasopharyngeal carcinoma by acting as a competing endogenous RNA to sponge miR‑431 and upregulate PBOV1.
Dong H, Huang C, Huang J
Mol Med Rep. 2021; 24(3).
PMID: 34278444
PMC: 8299196.
DOI: 10.3892/mmr.2021.12286.
Long noncoding RNA SLC9A3‑AS1 increases E2F6 expression by sponging microRNA‑486‑5p and thus facilitates the oncogenesis of nasopharyngeal carcinoma.
Li J, Li D, Zhang X, Li C, Zhu F
Oncol Rep. 2021; 46(2).
PMID: 34165171
PMC: 8218295.
DOI: 10.3892/or.2021.8116.
Stanniocalcin-2 promotes cell EMT and glycolysis via activating ITGB2/FAK/SOX6 signaling pathway in nasopharyngeal carcinoma.
Li J, Zhang Z, Feng X, Shen Z, Sun J, Zhang X
Cell Biol Toxicol. 2021; 38(2):259-272.
PMID: 33797657
PMC: 8986754.
DOI: 10.1007/s10565-021-09600-5.
Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).
Zhang S, Pan S, Liang S, Han Y, Chen H, Li J
Int J Oncol. 2021; 58(4).
PMID: 33649830
PMC: 7910009.
DOI: 10.3892/ijo.2021.5188.
[Effect of exosomes derived from human Epstein-Barr virus-positive nasopharyngeal carcinoma cells on lymphangiogenesis and lymph node metastasis].
Chen X, Li D, Huang Z, Zhong S, Cai L
Nan Fang Yi Ke Da Xue Xue Bao. 2020; 40(12):1776-1783.
PMID: 33380393
PMC: 7835692.
DOI: 10.12122/j.issn.1673-4254.2020.12.12.
Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.
Kang Y, He W, Ren C, Qiao J, Guo Q, Hu J
Signal Transduct Target Ther. 2020; 5(1):245.
PMID: 33093441
PMC: 7582884.
DOI: 10.1038/s41392-020-00340-2.
An Integrated Analysis of mRNAs and miRNAs Microarray Profiles to Screen miRNA Signatures Involved in Nasopharyngeal Carcinoma.
Liu L, Wang H, Yan C, Tao S
Technol Cancer Res Treat. 2020; 19:1533033820956998.
PMID: 32985354
PMC: 7534087.
DOI: 10.1177/1533033820956998.
PRDX1 is a Tumor Suppressor for Nasopharyngeal Carcinoma by Inhibiting PI3K/AKT/TRAF1 Signaling.
Xiao H, Yang T, Yan L, Feng J, Huang B, Jiang Y
Onco Targets Ther. 2020; 13:9123-9133.
PMID: 32982301
PMC: 7501964.
DOI: 10.2147/OTT.S252286.
Circular RNA Hsa_circ_0066755 as an Oncogene via sponging miR-651 and as a Promising Diagnostic Biomarker for Nasopharyngeal Carcinoma.
Wang J, Kong J, Nie Z, Chen D, Qiang J, Gao W
Int J Med Sci. 2020; 17(11):1499-1507.
PMID: 32669952
PMC: 7359393.
DOI: 10.7150/ijms.47024.